Blood traps may reveal lupus kidney treatment success
NCT ID NCT07721857
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
Lupus nephritis is a serious kidney complication of lupus that can lead to kidney failure. This study investigates whether levels of neutrophil extracellular traps (NETs)—web-like structures released by immune cells—in the blood can predict how well patients respond to therapy. Researchers will measure NETs in 100 adults with active lupus nephritis before and six months after starting treatment. If NETs prove to be a reliable marker, they could help doctors personalize treatment and monitor disease activity more effectively.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Measurement of neutrophil extracellular traps (NETs) in blood samples
- What this could lead to
- If NETs levels reliably predict treatment response, doctors could tailor lupus nephritis therapy earlier and more precisely, potentially improving outcomes.
- What could go wrong
- This is an observational, biomarker-focused study—not a treatment trial. NETs may not prove to be a reliable predictor, and results may not change clinical practice immediately.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS (LN) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app bridge the lupus care gap for women of color?
- A simple blood marker may reveal hidden heart risks in lupus
- Can a gentler steroid dose protect children's kidneys without the harsh side effects?
- Can a peer coach help young people take control of their chronic illness?
- Lupus patients may get a boost from doctors checking their prescription refill records
- Engineered immune cells take aim at Hard-to-Treat autoimmune diseases